Antipsychotic Selection
Ready to Claim Your Credits?
You have attempts to pass this post-test. Take your time and review carefully before submitting.
Good luck!
Overview
Psychiatrists have been buzzing about the CATIE trial ever since results were first published in 2005. Most non-psychiatrists are unaware of its widespread implications. What have we learned about antipsychotic selection? University of Michigan’s Director of Psychiatry Residency Education, Michael Jibson, MD discusses evidence based antipsychotic selection with host Dr. Leslie Lundt.
Overview
Psychiatrists have been buzzing about the CATIE trial ever since results were first published in 2005. Most non-psychiatrists are unaware of its widespread implications. What have we learned about antipsychotic selection? University of Michigan’s Director of Psychiatry Residency Education, Michael Jibson, MD discusses evidence based antipsychotic selection with host Dr. Leslie Lundt.
Title
Share on ReachMD
CloseProgram Chapters
Segment Chapters
Playlist:
Recommended
Updates From the 7th World Symposium Task Force
Episode 2 Part B: Effectively Transferring Over the CKD Patient at the Right Time
Integrating Guideline Directed Medical Therapy for Patients with CKD and T2D
HF Management for Patients with Comorbid Conditions
Pulmonary Hypertension Management: Practice Trends and Updates
Improving the IUD Experience: Evidence-Based Pain Management Approaches
Diagnosing and Treating Benign Prostatic Hyperplasia and Overactive Bladder
Bladders, Breakthroughs, and Bold New Therapies: Key Updates at AUA 2025
We’re glad to see you’re enjoying ReachMD…
but how about a more personalized experience?